XML 55 R37.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Shareholders' Equity and Share-Based Compensation (Tables)
12 Months Ended
Apr. 27, 2024
Equity [Abstract]  
Schedule of Nonvested Restricted Stock and Restricted Stock Units Activity
A summary of non-vested restricted stock and restricted stock units for fiscal years 2024, 2023, and 2022 is as follows:
Year Ended
April 27, 2024April 29, 2023April 30, 2022
Number of Nonvested Shares Weighted Average Grant Date
Fair Value Per Share
Number of Nonvested SharesWeighted Average Grant Date
Fair Value Per Share
Number of Nonvested SharesWeighted Average Grant Date
Fair Value Per Share
Outstanding at beginning of year617 $4.11 469 $5.65 480 $5.62 
Granted159 9.85 360 3.15 214 5.66 
Vested(280)3.92 (192)5.98 (213)5.58 
Forfeited(10)4.77 (20)4.98 (12)5.64 
Outstanding at end of year486 $5.95 617 $4.11 469 $5.65 
Share-based Payment Arrangement, Option, Activity A summary of stock option activity under our 2015 Plan and 2020 Plan during the fiscal year ended April 27, 2024 is as follows:
Stock Options Weighted Average Exercise Price
Per Share
Weighted Average Remaining
Contractual Life (Years)
Aggregate Intrinsic Value
Outstanding as of April 29, 2023
2,045 $7.11 5.52$858 
Granted37 9.85 — — 
Cancelled or forfeited(228)10.26 — — 
Exercised(219)5.94 — 708 
Outstanding as of April 27, 2024
1,635 $6.89 5.06$4,607 
   
Shares vested and expected to vest1,614 $6.93 5.03$4,503 
Exercisable as of April 27, 2024
1,034 $8.30 3.63$1,695 
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions
The following table provides the weighted-average fair value of options granted and the related assumptions used in the Black-Scholes model:
Year Ended
April 27, 2024April 29, 2023April 30, 2022
Fair value of options granted$4.92 $1.34 $2.43 
Risk-free interest rate4.37 %3.37 %1.07 %
Expected volatility46.28 %41.10 %40.60 %
Expected life of option (in years)6.906.936.94
Share-based Compensation Expense
The following table presents a summary of the share-based compensation expense by equity type as follows:
Year Ended
April 27, 2024April 29, 2023April 30, 2022
Stock options$420 $453 $458 
Restricted stock and stock units1,177 1,153 1,159 
Employee stock purchase plans493 421 356 
$2,090 $2,027 $1,973 
A summary of the share-based compensation expense for stock options, restricted stock, restricted stock units and shares issued under the ESPP for fiscal years 2024, 2023, and 2022 is as follows:
Year Ended
April 27, 2024April 29, 2023April 30, 2022
Cost of sales$452 $441 $434 
Selling437 424 472 
General and administrative745 735 656 
Product design and development456 427 411 
$2,090 $2,027 $1,973